Home » Topics » Regulatory

Regulatory
RSS

First medicine approved in E.U. for Cushing's disease

April 25, 2012

Alimera announces first marketing authorization for Iluvien in E.U.

April 25, 2012

Novartis seeking approval in Japan of Glivec for new indication

April 17, 2012

Eisai launches new formulation of rufinamide in U.K.

April 16, 2012

European Commission approves Humira for new indication

April 12, 2012

Korlym now available in U.S.

April 11, 2012

FDA approves adjunct radioactive diagnostic for Alzheimer's disease

April 10, 2012

New product approved for T-cell leukemia-lymphoma

March 30, 2012

Kiklin capsules approved in Japan

March 30, 2012

FDA approves line extension for etravirine

March 29, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...